18317/34347US=17 / Mono/Farmácia
Shiroma FCF. Radiofármacos: uma revisão. São Paulo, 2012. 59 p. -[Monografia de Conclusão do Curso de Pós Graduação Lato Sensu Farmácia Oncológica Fundação Antonio Prudente].

COMPOSTOS RADIOFARMACEUTICOS; MEDICINA NUCLEAR; NEOPLASIAS. TERAPIA; TOMOGRAFIA POR EMISSAO DE POSITRONS; TOMOGRAFIA COMPUTADORIZADA DE EMISSAO DE FOTON UNICO


18318/34347US=393 / Dissertacao
Barcelos CB. Eficácia da fonoterapia na imobilidade unilateral de prega vocal. [Efficacy of vocal therapy in unilateral vocal fold immobility]. São Paulo, 2012. 107 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2012/CamilaBarcelos/CamilaBarcelos.pdf

Curriculum Lattes

PREGAS VOCAIS; PARALISIS. REABILITACAO; PARESIA. REABILITACAO; FONOTERAPIA; QUALIDADE DE VIDA; EFICACIA DE TRATAMENTO


18319/34347US=394 / Dissertacao
Teodoro AL. O contato telefônico utilizado como estratégia de reforço à assistência do paciente em cuidados paliativos, seus familiares e cuidadores. [Telephone used as a means to support palliative care for the patient, his/her close relatives and caregivers]. São Paulo, 2012. 37 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2012/AnaTeodoro/AnaTeodoro.pdf

Curriculum Lattes

CUIDADOS PALIATIVOS; ASSISTENCIA AO PACIENTE. INSTRUMENTACAO; TELEFONE. INSTRUMENTACAO; CUIDADORES; AVALIACAO DE RESULTADOS DA ASSISTENCIA AO PACIENTE


18320/34347US=85 / Biol/Mol
Wesierska-Gadek J, Krystof V. Selective cyclin-dependent kinase inhibitors discriminating between cell cycle and transcriptional kinases: future reality or utopia?. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 228-41. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

CICLO CELULAR; CYC202; CICLINA-QUINASE DEPENDENTE; P53; ROSCOVITINA; TRANSCRICAO


18321/34347US=395 / Dissertacao
Fanni VSS. Expressão imunoistoquímica do receptor de FSH em tecido testicular tumoral, peritumoral, normal e de pacientes inférteis. [Immunohistochemical expression of FSH receptor in tumoral, peritumoral, normal and infertile patients testicular tissue]. São Paulo, 2012. 76 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2012/Victor/Victor.pdf

Curriculum Lattes

IMUNOISTOQUIMICA; NEOPLASIA TESTICULAR; SINDROME DA DISGENESIA TESTICULAR; INFERTILIDADE; HORMONIO FOLICULO ESTIMULANTE


18322/34347US=85 / Biol/Mol
Wandl S, Wesierska-Gadek J. Is olomoucine, a weak CDK2 inhibitor, able to induce apoptosis in cancer cells?. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 242-9. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

CDKS; G1; FARMACOLOGICA CDK2 INIBIDOR; G1 PRISAO; PARADA DO CICLO CELULAR; SUPRESSOR DE TUMOR P53; APOPTOSE


18323/34347US=396 / Dissertacao
Ferreira AC. Comparação dos níveis séricos de IL1B, IL6, IL8 e CCL2 entre indivíduos tabagistas e portadores de câncer de pulmão decélulas não-pequenas. [IL1B, IL8, IL6 and CCL2 serum level comparison in smokers and non-small cell lung cancer patients]. São Paulo, 2012. 55 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2012/AnaCFerreira/AnaCFerreira.pdf

Curriculum Lattes

CANCER PULMONAR DE CELULAS NAO PEQUENAS; INFLAMACAO; TABACO; CITOCINAS


18324/34347US=85 / Biol/Mol
Wandl S, Wesierska-Gadek J. Is olomoucine, a weak CDK2 inhibitor, able to induce apoptosis in cancer cells?. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 242-9. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

CDKS; FARMACOLOGICA CDK2 INIBIDOR; SUPRESSOR DE TUMOR P53; APOPTOSE; PRIVACAO DE SORO; PARADA DO CICLO CELULAR


18325/34347US=85 / Biol/Mol
Kramer MP, Wesierska-Gadek J. Monitoring of long-term effects of resveratrol on cell cycle progression of human HeLa cells after administration of a single dose. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 257-63. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

CICLO CELULAR; S-FASE DE SINCRONIZACAO; ROSCOVITINA; CICLO CELULAR RE-ENTRADA; SINER - EFEITO GISTIC


18326/34347US=85 / Biol/Mol
Fimognari C, Lenzi M, Cantelli-Forti G, Hrelia P. Apoptosi and modulation of cell cycle control by bile acids in human leukemia T cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 264-9. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

ACIDOS BILIARES; LEUCEMIA; APOPTOSE; CICLO CELULAR; G1; BLOQUEAR; TAURINA CONJUGADO


18327/34347US=85 / Biol/Mol
Kim SY, Kim JE, Lee KW, Lee HJ. Lactococcus lactis ssp. lactis inhibits the proliferation of SNU-1 human stomach cancer arrest and apoptosis via p53 and p21 expression. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 270-5. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

APOPTOSE; G0/G1 PARADA DO CICLO CELULAR; LACTOCOCCUS LACTIS SSP. LACTIS; CANCER DE ESTOMAGO


18328/34347US=85 / Biol/Mol
Thomadaki H, Floros KV, Scorilas A. Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new menber BCL2L12. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 276-83. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

LEUCEMIA PROMIELOCITICA AGUDA; APOPTOSE; BAX; BCL2; BCL2L12; CASPASE-3; CITOTOXICIDADE; LADDERING DNA; FAS; HL-60; INIBIDOR MITOTICO; MTT; PCR; TAXOL; VINCRISTINA


18329/34347US=89 / Biol/Mol
Jeong S, Lee HK, Kim MY. Use of RNA aptamers for the modulation of cancer cell signaling. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 363-77. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9.

APTAMEROS DE RNA; MODULACAO; SINALIZACAO; CANCER; TERAPIA ANTINEOPLASICA; CATENINA; CANCER DE COLON; RNA APTAMER; RNA INTRAMER; TCF; TUMORIGENESE


18330/34347US=89 / Biol/Mol
Bates PJ, Choi EW, Nayak LV. G-rich oligonucleotides for cancer treatment. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 379-92. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9.

APTAMEROS; CANCER; G-RICOS OLIGONUCLEOTIDOS; G-QUARTETOS; QUADRUPLEX; NUCLEOLIN


18331/34347US=85 / Biol/Mol
Keyhani E, Khavari-Nejad S, Keyhani J, Attar F. Acriflavine-mediated apoptosis and necrosis in yeast candida utilis. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 284-91. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

ACRIFLAVINA; APOPTOSE; NECROSE; MITOCONDRIAS; FLURESCENCE; RAZAO DE CONTROLE RESPIRATORIO; MICROSCOPIA ELETRONICA; ACIDIFICACAO DO CITOSOL; CANDIDA UTILIS


18332/34347US=89 / Biol/Mol
Laurencot CM, Ruppel S. Regulatory aspects for translating gene therapy research into the clinic. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 397-421. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9.

PESQUISA; TERAPIA GENETICA; ENSAIO CLINICO; FDA; GLP; GMP; DIRETRIZES REGULATORIAS


18333/34347US=89 / Biol/Mol
Kimmelman J. Ethics of cancer gene transfer clinical research. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 423-45. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9.

CANCER; ESTUDOS DE CORRELACAO; ETICA; TRANSFERENCIA DE GENES; CONSENTIMENTO INFORMADO; FASE 1; RISCO; VALOR


18334/34347US=89 / Biol/Mol
Vicente T, Peixoto C, Carrondo MJT, Alves PM. Virus production for clinical gene therapy. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 447-70. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9.

PRODUCAO DE VIRUS; TERAPIA GENETICA CLINICA; FERRAMENTAS ANALITICAS; CARACTERIZACAO; BACULOVIRUS RECOMBINANTES; PROCESSAMENTO; VETORES VIRAIS


18335/34347US=89 / Biol/Mol
Schleef M, Blaeses M. Production of plasmid DNA as a pharmaceutical. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 471-95. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9.

PRODUCAO DE DNA DE PLASMIDEO; PRODUTO FARMACEUTICO; ANALISE CGE; FABRICACAO DE CONTRATO; FERMENTACAO; TERAPIA GENICA; MINIPLASMIDEO; MINICIRCULOS; DNA DE PLASMIDEO; ESCALA FARMACEUTICA; TOPOLOGIA PLASMIDEO; GARANTIA DE QUALIDADE; CONTROLE DE QUALIDADE; VACINACAO; PRODUCAO VETORIAL


18336/34347US=85 / Biol/Mol
Attar F, Nejad SK, Keyhani J, Keyhani E. Structural and functional alterations of catalase induced by acriflavine, a compound causing apoptosis and necrosis. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 292-9. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

ACRIFLAVINA; CATALASE; ATIVIDADE ENZIMATICA; INIBICAO; STRUTURAL; ALTERACAO; ESPECTROFOTOMETRIA; FLUORESCENCIA; DICROISMO CIRCULAR


Primeira | Anterior | Próxima | Última